Nurix Therapeutics, Inc 10-Q for FY2022 Q3
Nurix Therapeutics, Inc. (NRIX)
10-Q
2022-10-06
For: 2022-08-31
View Original
Added on
April 11, 2026
About this 10-Q
Nurix Therapeutics, Inc filed this 10-Q on October 6, 2022, covering the quarter ended August 31, 2022 (FY2022 Q3).
Headline figures
Quarter ended August 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $10.79M
- up 5.3% from $10.25M a year earlier
- Net loss
- $45.71M
- compared with a net loss of $28.84M a year earlier
- Diluted EPS
- -$0.90
- compared with -$0.65 a year earlier